Structure Therapeutics In... (GPCR)
undefined
undefined%
At close: undefined
31.29
0.33%
After-hours Dec 13, 2024, 05:46 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue - - - -
Cost of Revenue 949.17K 623.26K 266.35K 20.03K
Gross Profit -949.17K -623.26K -266.35K -20.03K
Operating Income -102.78M -52.56M -37.70K -15.91K
Interest Income 13.38M 1.26M 122.00 168.29K
Pretax Income -89.38M -51.30M -37.82K -15.74K
Net Income -89.62M -51.32M -38.05K -15.88K
Selling & General & Admin 32.67M 16.37M 8.59K 3.54K
Research & Development 70.10M 36.19M 29.11K 12.36K
Other Expenses 0.00 - - -
Operating Expenses 102.78M 52.56M 37.70K 15.91K
Interest Expense 13.39M - 122.16K -
Selling & Marketing Expenses - - - -
Cost & Expenses 102.78M 52.56M 37.70K 15.91K
Income Tax 236.00K 17.00K 231.00 138.00
Shares Outstanding (Basic) 36.73M 36.59M 36.59M 36.59M
Shares Outstanding (Diluted) 36.73M 36.59M 36.59M 36.59M
EPS (Basic) -2.44 -1.4 -0.00 -0.00
EPS (Diluted) -2.44 -1.4 -0.00 -0.00
EBITDA -102.78M -52.28M -37.62M -15.75M
Depreciation & Amortization 316.00K 623.26K 266.35K 20.03K